Intercalated theophylline-smectite hybrid for pH-mediated delivery

Area of Science:

• Materials Science
• Pharmaceutical Sciences
• Clay Science

Background:

• Natural smectite clays offer high surface area and low toxicity, making them suitable for drug delivery.
• Theophylline, a bronchodilator for asthma, requires controlled release for optimal therapeutic effect.

Purpose of the Study:

• To investigate the in vitro uptake and release of theophylline by smectite clay.
• To characterize the theophylline-smectite hybrid system and assess its potential for gastric protection and intestinal release.

Main Methods:

• Ion exchange of cationic theophylline into smectite clay at pH 1.2.
• Characterization using powder X-ray diffraction, FTIR, DSC, and SEM.
• In vitro release studies in simulated gastric (pH 1.2) and intestinal fluids (pH 6.8, 7.4).

Main Results:

• Maximum theophylline uptake by smectite clay was 67 ± 2 mg g⁻¹ at pH 1.2.
• Characterization confirmed amorphous theophylline intercalation within the clay structure.
• Theophylline remained bound under simulated gastric conditions and showed prolonged release (approx. 40% in 2h) in simulated intestinal fluid.

Conclusions:

• Smectite clay is a promising vehicle for theophylline delivery, enabling gastric protection.
• The drug-clay interaction, involving chemisorption, leads to prolonged release in the intestine.
• This controlled release profile may reduce serum concentration fluctuations, enhancing therapeutic efficacy and safety.